Open access
Sep 2026
Disulfiram reverses fluconazole-resistance mediated by Cdr1 in Candida albicans and interferes with biofilm formation
The incidence of Candida albicans infections has risen markedly, particularly among immunocompromised individuals and cancer patients undergoing chemotherapy. Fluconazole is commonly used as a first-line treatment for C. albicans infections; however, increasing clinical resistance poses a significant therapeutic challe...
A. Rezk, H. Said, Sherin M. Elfeky et al.
· Applied Microbiology and Bio... · 0 citations